Trial Profile
Phase I trial of palbociclib in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Mar 2018
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Palbociclib (Primary)
- Indications Carcinoma; Head and neck cancer; Squamous cell cancer
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 27 Mar 2018 New trial record